US tariffs, IP issues threaten patient access Viveka Roychowdhury Apr 1, 2025 The judgements on the Roche Natco case for SMA medicine risdiplam could impact petitions from patients suffering from other rare…
Roche gets US FDA approval for Evrysdi to treat spinal muscular atrophy EP News Bureau Aug 11, 2020 In two clinical trials, Evrysdi improved motor function in people living with SMA over a broad spectrum of ages and levels of…
Roche’s SMA drug trial win bolsters $2 billion sales prospects Reuters Jan 23, 2020 US regulators are due to decide by May 24
